The discovery of high affinity and metabolically stable allosteric cyclin-dependent kinase 2 (CDK2) inhibitors from screening through lead optimization
Erik B. Faber(University of Minnesota), Gunda I. Georg(University of Minnesota), Rawle Francis(University of Minnesota), Nicholas Levinson(University of Minnesota Medical Center), David J. Burban(University of Minnesota), Luxin Sun(Moffitt Cancer Center), Kwon Ho Hong(University of Minnesota), Defeng Tian(University of Minnesota), Jon E. Hawkinson(University of Minnesota), H.L.S. Wong(University of Minnesota), Kristen John(University of Minnesota), Mazen Elsaid(University of Minnesota), Liming Wang(Chinese Academy of Sciences), Nan Wang(University of Minnesota), An‐Suei Yang(Genomics Research Center, Academia Sinica), Hira Khalid(University of Minnesota), E. Schönbrunn(Moffitt Cancer Center)
Cited by 1
Related Papers
Bismuth Sulfide Nanorods as a Precision Nanomedicine for<i>in Vivo</i>Multimodal Imaging-Guided Photothermal Therapy of Tumor
|ACS Nano|2015|555
Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors
|Cell|2015|340
Transforming growth factor beta enhances integrin expression and type IV collagenase secretion in human monocytes.
|Proceedings of the National Academy of Sciences|1993|209
Interaction of gold nanoparticles with proteins and cells
|Science and Technology of Advanced Materials|2015|209
Suppression of monocyte function and differential regulation of IL-1 and IL-1ra by IL-4 contribute to resolution of experimental arthritis.
|The Journal of Immunology|1993|169